Read the Latest News
or Download our Publications.

3. May 2022

Cardea Bio receives funding to develop electronic nose to rapidly diagnose infectious diseases via breath

Today, Cardea Bio, Inc. - the world's only mass producer of biocompatible semiconductors -...
Read more

27. April 2022

Securing international patents for mass-produced graphene biosensors

Today, Cardea Bio, Inc. - the world's first mass producer of graphene biosensors - shares their...
Read more

5. April 2022

Cardea Bio completes planned launch of CRISPR QC

San Diego, CA -- April 5, 2022 -- Today, Cardea Bio, Inc. - the world’s only mass producer of...
Read more

2. February 2022

Dr. Kiana Aran Receives NIH Funding to Help Set Quality Control Standards for CRISPR Therapies

Dr. Kiana Aran, Associate Professor of Medical Diagnostics and Therapeutics and head of the Aran...
Read more

10. January 2022

Cardea announces a collaboration agreement with Siemens Healthineers to assess feasibility of real-time applications

San Diego, CA -- January 10, 2022 -- Today, Cardea Bio, Inc. - the world’s only mass producer of...
Read more

9. December 2021

Cardea Bio accelerates commercial platform due to demand from market moving partners

To signal that Cardea Bio, Inc. is investing significantly into the commercialization efforts of...
Read more

22. June 2021

Cardea Bio Appoints Experienced Health Technology Executive, Dr. Kelly Huang, as Chief Operating Officer

Expanded Leadership Team Supports Continued Operational and Commercial Growth SAN DIEGO--(BUSINESS...
Read more

6. May 2021

The New EV-Chip Biosensor Detects Exosome Cancer & Aging Biomarkers

As the worldwide population ages, a significant challenge will be for healthcare systems to meet...
Read more

4. May 2021

Cardea Bio Develops Exosome and Extracellular Vesicles (EV) Detection Technology Called EV-Chip, Showcasing Cancer and Aging Dx Applications

EV-Chip paves way for new generation of portable, point-of-care devices Enables real-time analysis...
Read more

4. May 2021

Biotome Partners with Cardea Bio to Develop Graphene-based Precision Immunology Diagnostic Platform

Perth, Australia – May 4, 2021 - Precision diagnostics company Biotome Pty Ltd has entered into a...
Read more